nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—NR3C2—Prednisolone—chronic obstructive pulmonary disease	0.155	0.394	CbGbCtD
Spironolactone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.051	0.13	CbGbCtD
Spironolactone—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0482	0.123	CbGbCtD
Spironolactone—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.044	0.112	CbGbCtD
Spironolactone—Potassium Canrenoate—Prednisone—chronic obstructive pulmonary disease	0.0431	0.0881	CrCrCtD
Spironolactone—Potassium Canrenoate—Prednisolone—chronic obstructive pulmonary disease	0.0421	0.086	CrCrCtD
Spironolactone—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0415	0.106	CbGbCtD
Spironolactone—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.0317	0.0647	CrCrCtD
Spironolactone—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.0309	0.0631	CrCrCtD
Spironolactone—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.0307	0.0627	CrCrCtD
Spironolactone—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.0299	0.0612	CrCrCtD
Spironolactone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0299	0.0762	CbGbCtD
Spironolactone—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.0298	0.0608	CrCrCtD
Spironolactone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.0291	0.0594	CrCrCtD
Spironolactone—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.0267	0.0546	CrCrCtD
Spironolactone—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0266	0.0545	CrCrCtD
Spironolactone—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.026	0.0532	CrCrCtD
Spironolactone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.026	0.0532	CrCrCtD
Spironolactone—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.026	0.0531	CrCrCtD
Spironolactone—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.0254	0.0518	CrCrCtD
Spironolactone—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.0226	0.0461	CrCrCtD
Spironolactone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0217	0.0444	CrCrCtD
Spironolactone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0212	0.0433	CrCrCtD
Spironolactone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0119	0.0303	CbGbCtD
Spironolactone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0112	0.0286	CbGbCtD
Spironolactone—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00175	0.0263	CcSEcCtD
Spironolactone—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.0239	CcSEcCtD
Spironolactone—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00154	0.0231	CcSEcCtD
Spironolactone—Gastritis—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.0189	CcSEcCtD
Spironolactone—Breast pain—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0161	CcSEcCtD
Spironolactone—Hypertrichosis—Prednisone—chronic obstructive pulmonary disease	0.00103	0.0154	CcSEcCtD
Spironolactone—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.000997	0.015	CcSEcCtD
Spironolactone—Hyperkalaemia—Arformoterol—chronic obstructive pulmonary disease	0.000976	0.0146	CcSEcCtD
Spironolactone—Hyperkalaemia—Formoterol—chronic obstructive pulmonary disease	0.000976	0.0146	CcSEcCtD
Spironolactone—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.000972	0.0146	CcSEcCtD
Spironolactone—Cramps of lower extremities—Arformoterol—chronic obstructive pulmonary disease	0.000912	0.0137	CcSEcCtD
Spironolactone—Cramps of lower extremities—Formoterol—chronic obstructive pulmonary disease	0.000912	0.0137	CcSEcCtD
Spironolactone—Cramps of lower extremities—Salbutamol—chronic obstructive pulmonary disease	0.000862	0.0129	CcSEcCtD
Spironolactone—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000822	0.0123	CcSEcCtD
Spironolactone—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.000794	0.0119	CcSEcCtD
Spironolactone—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.000771	0.0116	CcSEcCtD
Spironolactone—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00072	0.0108	CcSEcCtD
Spironolactone—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.000706	0.0106	CcSEcCtD
Spironolactone—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.000677	0.0102	CcSEcCtD
Spironolactone—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.000649	0.00974	CcSEcCtD
Spironolactone—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.000649	0.00974	CcSEcCtD
Spironolactone—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00064	0.0096	CcSEcCtD
Spironolactone—Gastritis—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00957	CcSEcCtD
Spironolactone—Gastritis—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00957	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.000636	0.00954	CcSEcCtD
Spironolactone—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.000636	0.00954	CcSEcCtD
Spironolactone—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.0092	CcSEcCtD
Spironolactone—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00906	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00904	CcSEcCtD
Spironolactone—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000579	0.00869	CcSEcCtD
Spironolactone—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000575	0.00863	CcSEcCtD
Spironolactone—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000555	0.00832	CcSEcCtD
Spironolactone—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.000551	0.00827	CcSEcCtD
Spironolactone—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000544	0.00816	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00054	0.00809	CcSEcCtD
Spironolactone—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00787	CcSEcCtD
Spironolactone—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000514	0.00772	CcSEcCtD
Spironolactone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000478	0.00717	CcSEcCtD
Spironolactone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000466	0.00698	CcSEcCtD
Spironolactone—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000462	0.00693	CcSEcCtD
Spironolactone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000462	0.00693	CcSEcCtD
Spironolactone—PGR—respiratory system—chronic obstructive pulmonary disease	0.000453	0.0684	CbGeAlD
Spironolactone—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000445	0.00667	CcSEcCtD
Spironolactone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000444	0.00666	CcSEcCtD
Spironolactone—SHBG—connective tissue—chronic obstructive pulmonary disease	0.000443	0.0668	CbGeAlD
Spironolactone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00044	0.0066	CcSEcCtD
Spironolactone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00044	0.0066	CcSEcCtD
Spironolactone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000437	0.00656	CcSEcCtD
Spironolactone—NR3C2—connective tissue—chronic obstructive pulmonary disease	0.000429	0.0647	CbGeAlD
Spironolactone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.00626	CcSEcCtD
Spironolactone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000417	0.00626	CcSEcCtD
Spironolactone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000415	0.00622	CcSEcCtD
Spironolactone—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000413	0.0062	CcSEcCtD
Spironolactone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000409	0.00613	CcSEcCtD
Spironolactone—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000403	0.00604	CcSEcCtD
Spironolactone—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000403	0.00604	CcSEcCtD
Spironolactone—NR3C2—bronchus—chronic obstructive pulmonary disease	0.000401	0.0605	CbGeAlD
Spironolactone—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00601	CcSEcCtD
Spironolactone—PGR—connective tissue—chronic obstructive pulmonary disease	0.000399	0.0602	CbGeAlD
Spironolactone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000394	0.00591	CcSEcCtD
Spironolactone—NR3C2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000393	0.0592	CbGeAlD
Spironolactone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00587	CcSEcCtD
Spironolactone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00587	CcSEcCtD
Spironolactone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00571	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00569	CcSEcCtD
Spironolactone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00037	0.00555	CcSEcCtD
Spironolactone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00555	CcSEcCtD
Spironolactone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000368	0.00552	CcSEcCtD
Spironolactone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00548	CcSEcCtD
Spironolactone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00548	CcSEcCtD
Spironolactone—PGR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000365	0.055	CbGeAlD
Spironolactone—NR3C2—trachea—chronic obstructive pulmonary disease	0.00036	0.0543	CbGeAlD
Spironolactone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00532	CcSEcCtD
Spironolactone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00532	CcSEcCtD
Spironolactone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000349	0.00523	CcSEcCtD
Spironolactone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00521	CcSEcCtD
Spironolactone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00517	CcSEcCtD
Spironolactone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000343	0.00515	CcSEcCtD
Spironolactone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00034	0.0051	CcSEcCtD
Spironolactone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00502	CcSEcCtD
Spironolactone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000329	0.00494	CcSEcCtD
Spironolactone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00485	CcSEcCtD
Spironolactone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000319	0.00478	CcSEcCtD
Spironolactone—AR—connective tissue—chronic obstructive pulmonary disease	0.000318	0.0479	CbGeAlD
Spironolactone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000315	0.00473	CcSEcCtD
Spironolactone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.00473	CcSEcCtD
Spironolactone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000311	0.00466	CcSEcCtD
Spironolactone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000309	0.00463	CcSEcCtD
Spironolactone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00462	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00459	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00459	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00449	CcSEcCtD
Spironolactone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00446	CcSEcCtD
Spironolactone—AR—bronchus—chronic obstructive pulmonary disease	0.000297	0.0448	CbGeAlD
Spironolactone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.00444	CcSEcCtD
Spironolactone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.0044	CcSEcCtD
Spironolactone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000293	0.0044	CcSEcCtD
Spironolactone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00438	CcSEcCtD
Spironolactone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00438	CcSEcCtD
Spironolactone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000292	0.00438	CcSEcCtD
Spironolactone—AR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000291	0.0438	CbGeAlD
Spironolactone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00436	CcSEcCtD
Spironolactone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00434	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00433	CcSEcCtD
Spironolactone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00422	CcSEcCtD
Spironolactone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00422	CcSEcCtD
Spironolactone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00028	0.0042	CcSEcCtD
Spironolactone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.0042	CcSEcCtD
Spironolactone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000279	0.00419	CcSEcCtD
Spironolactone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000277	0.00415	CcSEcCtD
Spironolactone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000277	0.00415	CcSEcCtD
Spironolactone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.00415	CcSEcCtD
Spironolactone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00414	CcSEcCtD
Spironolactone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00414	CcSEcCtD
Spironolactone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000275	0.00413	CcSEcCtD
Spironolactone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000274	0.00412	CcSEcCtD
Spironolactone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00399	CcSEcCtD
Spironolactone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00397	CcSEcCtD
Spironolactone—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000262	0.0394	CbGeAlD
Spironolactone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00392	CcSEcCtD
Spironolactone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00392	CcSEcCtD
Spironolactone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00391	CcSEcCtD
Spironolactone—NR3C2—lung—chronic obstructive pulmonary disease	0.000259	0.039	CbGeAlD
Spironolactone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00384	CcSEcCtD
Spironolactone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00376	CcSEcCtD
Spironolactone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00376	CcSEcCtD
Spironolactone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.0037	CcSEcCtD
Spironolactone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00368	CcSEcCtD
Spironolactone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00364	CcSEcCtD
Spironolactone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00364	CcSEcCtD
Spironolactone—PGR—lung—chronic obstructive pulmonary disease	0.000241	0.0363	CbGeAlD
Spironolactone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00356	CcSEcCtD
Spironolactone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00355	CcSEcCtD
Spironolactone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00352	CcSEcCtD
Spironolactone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00352	CcSEcCtD
Spironolactone—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.00023	0.0347	CbGeAlD
Spironolactone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00344	CcSEcCtD
Spironolactone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00343	CcSEcCtD
Spironolactone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00339	CcSEcCtD
Spironolactone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00338	CcSEcCtD
Spironolactone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00338	CcSEcCtD
Spironolactone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00335	CcSEcCtD
Spironolactone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00335	CcSEcCtD
Spironolactone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00335	CcSEcCtD
Spironolactone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00335	CcSEcCtD
Spironolactone—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000222	0.0335	CbGeAlD
Spironolactone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00333	CcSEcCtD
Spironolactone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00333	CcSEcCtD
Spironolactone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00332	CcSEcCtD
Spironolactone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00331	CcSEcCtD
Spironolactone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00328	CcSEcCtD
Spironolactone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00328	CcSEcCtD
Spironolactone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00327	CcSEcCtD
Spironolactone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00326	CcSEcCtD
Spironolactone—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000215	0.0325	CbGeAlD
Spironolactone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00319	CcSEcCtD
Spironolactone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00318	CcSEcCtD
Spironolactone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00316	CcSEcCtD
Spironolactone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00316	CcSEcCtD
Spironolactone—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000211	0.0318	CbGeAlD
Spironolactone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00316	CcSEcCtD
Spironolactone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00316	CcSEcCtD
Spironolactone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00314	CcSEcCtD
Spironolactone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00309	CcSEcCtD
Spironolactone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00298	CcSEcCtD
Spironolactone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.00297	CcSEcCtD
Spironolactone—NR3C1—trachea—chronic obstructive pulmonary disease	0.000193	0.0291	CbGeAlD
Spironolactone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.00288	CcSEcCtD
Spironolactone—AR—lung—chronic obstructive pulmonary disease	0.000192	0.0289	CbGeAlD
Spironolactone—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.0026	CcSEcCtD
Spironolactone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00238	CcSEcCtD
Spironolactone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00237	CcSEcCtD
Spironolactone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00231	CcSEcCtD
Spironolactone—CYP11B1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000154	0.00347	CbGpPWpGaD
Spironolactone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00229	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000149	0.00335	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000147	0.00332	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000147	0.00331	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000146	0.00328	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000146	0.00328	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000145	0.00326	CbGpPWpGaD
Spironolactone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00216	CcSEcCtD
Spironolactone—CYP11B1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000144	0.00323	CbGpPWpGaD
Spironolactone—CYP11B1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000142	0.00319	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	0.000141	0.00318	CbGpPWpGaD
Spironolactone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00212	CcSEcCtD
Spironolactone—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00014	0.0211	CbGeAlD
Spironolactone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00209	CcSEcCtD
Spironolactone—NR3C1—lung—chronic obstructive pulmonary disease	0.000139	0.0209	CbGeAlD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000138	0.0031	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000137	0.00309	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000137	0.00308	CbGpPWpGaD
Spironolactone—CYP11B1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00306	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000135	0.00303	CbGpPWpGaD
Spironolactone—CYP11B1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.00302	CbGpPWpGaD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.00302	CbGpPWpGaD
Spironolactone—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00298	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000132	0.00297	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000131	0.00295	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.000129	0.00291	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000127	0.00286	CbGpPWpGaD
Spironolactone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.0019	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000126	0.00283	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000125	0.00282	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000124	0.00279	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000123	0.00277	CbGpPWpGaD
Spironolactone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00182	CcSEcCtD
Spironolactone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00181	CcSEcCtD
Spironolactone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.0018	CcSEcCtD
Spironolactone—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000119	0.00267	CbGpPWpGaD
Spironolactone—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.000115	0.00259	CbGpPWpGaD
Spironolactone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00172	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000115	0.00258	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	0.000114	0.00257	CbGpPWpGaD
Spironolactone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00171	CcSEcCtD
Spironolactone—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00254	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000112	0.00252	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000111	0.00251	CbGpPWpGaD
Spironolactone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00166	CcSEcCtD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	0.00011	0.00248	CbGpPWpGaD
Spironolactone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00165	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000109	0.00246	CbGpPWpGaD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.00244	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000106	0.00238	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000105	0.00236	CbGpPWpGaD
Spironolactone—ABCB1—trachea—chronic obstructive pulmonary disease	0.000103	0.0156	CbGeAlD
Spironolactone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00154	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000102	0.0023	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000102	0.00229	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.0001	0.00226	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.93e-05	0.00224	CbGpPWpGaD
Spironolactone—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.00148	CcSEcCtD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.73e-05	0.00219	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	9.65e-05	0.00217	CbGpPWpGaD
Spironolactone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.61e-05	0.00216	CbGpPWpGaD
Spironolactone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.00143	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	9.53e-05	0.00215	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	9.34e-05	0.0021	CbGpPWpGaD
Spironolactone—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.22e-05	0.00138	CcSEcCtD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.06e-05	0.00204	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	9.04e-05	0.00204	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	8.92e-05	0.00201	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	8.9e-05	0.002	CbGpPWpGaD
Spironolactone—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.87e-05	0.00133	CcSEcCtD
Spironolactone—Rash—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.00132	CcSEcCtD
Spironolactone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.78e-05	0.00132	CcSEcCtD
Spironolactone—Headache—Prednisone—chronic obstructive pulmonary disease	8.74e-05	0.00131	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.65e-05	0.00195	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	8.62e-05	0.00194	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	8.46e-05	0.0019	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.41e-05	0.00189	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	8.39e-05	0.00189	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.34e-05	0.00188	CbGpPWpGaD
Spironolactone—Progesterone—CYP1A1—chronic obstructive pulmonary disease	8.31e-05	0.23	CrCbGaD
Spironolactone—Nausea—Prednisone—chronic obstructive pulmonary disease	8.28e-05	0.00124	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—GC—chronic obstructive pulmonary disease	8.18e-05	0.00184	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	8.05e-05	0.00181	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	8.03e-05	0.00181	CbGpPWpGaD
Spironolactone—Progesterone—CYP1A2—chronic obstructive pulmonary disease	8.02e-05	0.222	CrCbGaD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.89e-05	0.00178	CbGpPWpGaD
Spironolactone—Testosterone—CYP1A1—chronic obstructive pulmonary disease	7.86e-05	0.218	CrCbGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.8e-05	0.00176	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	7.75e-05	0.00175	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	7.7e-05	0.00173	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.61e-05	0.00171	CbGpPWpGaD
Spironolactone—Methyltestosterone—ALB—chronic obstructive pulmonary disease	7.55e-05	0.209	CrCbGaD
Spironolactone—ABCB1—lung—chronic obstructive pulmonary disease	7.44e-05	0.0112	CbGeAlD
Spironolactone—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	7.38e-05	0.00166	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	7.28e-05	0.00164	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.25e-05	0.00163	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.19e-05	0.00162	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	7.18e-05	0.00162	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	7.09e-05	0.0016	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GC—chronic obstructive pulmonary disease	7.05e-05	0.00159	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.94e-05	0.00156	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	6.86e-05	0.00154	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.86e-05	0.00154	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	6.86e-05	0.00154	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	6.86e-05	0.00154	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	6.82e-05	0.00154	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.56e-05	0.00148	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	6.4e-05	0.00144	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	6.36e-05	0.00143	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—CTGF—chronic obstructive pulmonary disease	6.34e-05	0.00143	CbGpPWpGaD
Spironolactone—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	6.14e-05	0.00138	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	6.11e-05	0.00138	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.06e-05	0.00136	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	6.01e-05	0.00135	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	6e-05	0.00135	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.91e-05	0.00133	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	5.79e-05	0.0013	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.77e-05	0.0013	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.69e-05	0.00128	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.59e-05	0.00126	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	5.47e-05	0.00123	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.36e-05	0.00121	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.35e-05	0.0012	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.24e-05	0.00118	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.22e-05	0.00118	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	4.94e-05	0.00111	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.89e-05	0.0011	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.88e-05	0.0011	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.81e-05	0.00108	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.75e-05	0.00107	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.66e-05	0.00105	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	4.64e-05	0.00104	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.55e-05	0.00102	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.54e-05	0.00102	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	4.52e-05	0.00102	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.51e-05	0.00101	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.47e-05	0.00101	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	4.42e-05	0.000995	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.42e-05	0.000995	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.42e-05	0.000995	CbGpPWpGaD
Spironolactone—Testosterone—ALB—chronic obstructive pulmonary disease	4.38e-05	0.121	CrCbGaD
Spironolactone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.36e-05	0.000982	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	4.35e-05	0.00098	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.24e-05	0.000954	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	4.21e-05	0.000947	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.19e-05	0.000944	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.19e-05	0.000944	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.17e-05	0.000938	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.13e-05	0.000931	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.12e-05	0.000928	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.11e-05	0.000925	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.07e-05	0.000915	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.03e-05	0.000908	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	3.98e-05	0.000897	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.97e-05	0.000894	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	3.93e-05	0.000884	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.89e-05	0.000876	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.86e-05	0.00087	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.86e-05	0.000869	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.85e-05	0.000867	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.81e-05	0.000857	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.81e-05	0.000857	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.77e-05	0.000848	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.72e-05	0.000836	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.68e-05	0.000829	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.66e-05	0.000824	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	3.66e-05	0.000823	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.6e-05	0.00081	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.55e-05	0.000799	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.54e-05	0.000797	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.53e-05	0.000794	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.52e-05	0.000792	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.48e-05	0.000782	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.47e-05	0.000782	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.44e-05	0.000775	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	3.41e-05	0.000769	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.37e-05	0.000759	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.31e-05	0.000745	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.28e-05	0.000737	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.21e-05	0.000723	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.2e-05	0.000721	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.2e-05	0.000721	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.19e-05	0.000718	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.14e-05	0.000707	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.1e-05	0.000698	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.06e-05	0.000688	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.95e-05	0.000664	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.94e-05	0.000663	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.94e-05	0.000661	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.93e-05	0.000659	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.92e-05	0.000656	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.89e-05	0.000651	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.85e-05	0.000641	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.79e-05	0.000627	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	2.76e-05	0.00062	CbGpPWpGaD
Spironolactone—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.74e-05	0.000617	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.73e-05	0.000615	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.7e-05	0.000608	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.67e-05	0.000601	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.63e-05	0.000593	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.45e-05	0.000552	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.42e-05	0.000544	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.4e-05	0.000541	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.39e-05	0.000538	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.38e-05	0.000536	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.34e-05	0.000527	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.33e-05	0.000524	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.23e-05	0.000503	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.23e-05	0.000503	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.23e-05	0.000501	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.22e-05	0.000499	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.18e-05	0.000491	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.18e-05	0.00049	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.17e-05	0.000489	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.12e-05	0.000477	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.11e-05	0.000476	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.08e-05	0.000468	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.02e-05	0.000455	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.01e-05	0.000452	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.01e-05	0.000452	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.95e-05	0.000438	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.93e-05	0.000434	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.000426	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ALB—chronic obstructive pulmonary disease	1.84e-05	0.000413	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.79e-05	0.000404	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.76e-05	0.000397	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.76e-05	0.000396	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.76e-05	0.000395	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.67e-05	0.000377	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.65e-05	0.000372	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.63e-05	0.000367	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.61e-05	0.000362	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.58e-05	0.000356	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.57e-05	0.000354	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.000353	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.54e-05	0.000346	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.51e-05	0.000341	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.00034	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.46e-05	0.000329	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.46e-05	0.000328	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.44e-05	0.000325	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.42e-05	0.000319	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.35e-05	0.000303	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.34e-05	0.000302	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.19e-05	0.000268	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.19e-05	0.000267	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.17e-05	0.000264	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.15e-05	0.000258	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.09e-05	0.000246	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.000246	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.07e-05	0.000241	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000233	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.00023	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.02e-05	0.000229	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	9.92e-06	0.000223	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.87e-06	0.000222	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.7e-06	0.000218	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.49e-06	0.000214	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.33e-06	0.00021	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.06e-06	0.000204	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.77e-06	0.000197	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.6e-06	0.000193	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.23e-06	0.000185	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.12e-06	0.000183	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.88e-06	0.000177	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.56e-06	0.00017	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.23e-06	0.000163	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.17e-06	0.000161	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.17e-06	0.000161	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.09e-06	0.00016	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.07e-06	0.000159	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.59e-06	0.000148	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.25e-06	0.000141	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.95e-06	0.000134	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.45e-06	0.000123	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.87e-06	0.00011	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.66e-06	0.000105	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.25e-06	9.56e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.06e-06	9.14e-05	CbGpPWpGaD
